Neyt, Mattias; Huybrechts, Michel; Hulstaert, Frank; … - In: Health Policy 87 (2008) 2, pp. 146-159
Objectives Although trastuzumab is traditionally used in metastatic breast cancer treatment, studies reported on the efficacy and safety of trastuzumab in adjuvant setting for the treatment of early stage breast cancer in HER2+ tumors. We estimated the cost-effectiveness and budget impact of...